42
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Brick by brick: metformin for gestational diabetes mellitus?

, &
Pages 353-357 | Published online: 10 Jan 2014

References

  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of Type 2 diabetes: a systematic review. Diabetes Care25(10), 1862–1868 (2002).
  • Ma RC, Chan JC. Pregnancy and diabetes scenario around the world: China. Int. J. Gynaecol. Obstet.104(Suppl. 1), S42–S45 (2009).
  • Coetzee EJ. Pregnancy and diabetes scenario around the world: Africa. Int. J. Gynaecol. Obstet.104(Suppl 1), S39–S41 (2009).
  • Seshiah V, Balaji V, Balaji MS et al. Prevalence of gestational diabetes mellitus in South India (Tamil Nadu) – a community based study. J. Assoc. Physicians India56, 329–333 (2008).
  • Ismail-Beigi F, Catalano PM, Hanson RW. Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult. Am. J. Physiol. Endocrinol. Metab.291(3), E439–E440 (2006).
  • Keely EJ, Malcolm JC, Hadjiyannakis S, Gaboury I, Lough G, Lawson ML. Prevalence of metabolic markers of insulin resistance in offspring of gestational diabetes pregnancies. Pediatr. Diabetes9(1), 53–59 (2008).
  • Schaefer-Graf UM, Pawliczak J, Passow D et al. Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care28(7), 1745–1750 (2005).
  • Crowther CA, Hiller JE, Moss JR et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med.352(24), 2477–2486 (2005).
  • Landon MB, Spong CY, Thom E et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med.361(14), 1339–1348 (2009).
  • Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care30(9), 2287–2292 (2007).
  • Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med.358(19), 2003–2015 (2008).
  • Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med.343(16), 1134–1138 (2000).
  • Chen Y, Quick WW, Yang W et al. Cost of gestational diabetes mellitus in the United States in 2007. Popul. Health. Manag.12(3), 165–174 (2009).
  • Rai L, Meenakshi D, Kamath A. Metformin – a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian J. Med. Sci.63(11), 491–497 (2009).
  • Balani J, Hyer SL, Rodin DA, Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabet. Med.26(8), 798–802 (2009).
  • Mastrogiannis DS, Spiliopoulos M, Mulla W, Homko CJ. Insulin resistance: the possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy. Curr. Diab. Rep.9(4), 296–302 (2009).
  • Holdsworth-Carson S, Lim R, Mitton A et al. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta31(3), 222–229 (2010).
  • Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet. Gynecol.115(1), 55–59 (2010).
  • Brown FM, Wyckoff J, Rowan JA, Jovanovic L, Sacks DA, Briggs GG. Metformin in pregnancy: its time has not yet come. Diabetes Care29(2), 485–486 (2006).
  • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can. J. Diabetes32, S1–S201 (2008).
  • IDF Clinical Guidelines Task Force. Global Guideline on Pregnancy and Diabetes. International Diabetes Federation, Brussels, Belgium (2009).
  • Gutzin SJ, Kozer E, Magee LA, Feig DS, Koren G. The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis. Can. J. Clin. Pharmacol.10(4), 179–183 (2003).
  • Allen VM, Armson BA. Tératogénicité associée aux diabètes gestationnel et préexistant. JOGC200, 935–944 (2007).
  • Glueck CJ, Pranikoff J, Aregawi D, Wang P. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil. Steril.89(3), 625–634 (2008).
  • Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum. Reprod.19(3), 510–521 (2004).
  • Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J. Management of diabetes mellitus by obstetrician-gynecologists. Obstet. Gynecol.103(6), 1229–1234 (2004).

Website

  • National Collaborating Centre for Women’s and Children’s Health. Clinical guidelines CG63 Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period (March 2008; revised reprint July 2008) www.nice.org.uk/CG063

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.